Internal Medicine, Hematology & Oncology · Hartford, CT
NPI
1700129541
Since 2013
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
7
Medicare group memberships
Hospitals
1
Hospital affiliations
85 Retreat Ave
Hartford, CT, 06106
Phone (860) 972-4183
Groups this clinician bills Medicare through
Medicare paid, 2024
$34K
300 services
Medicare patients, 2024
121
Average age 74
Drug cost, 2024
$1.3M
309 prescriptions
Company payments, 2024
$7,142
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Kin Wai Hung was code 99215 (office e&m - established), 224 times for 97 patients. In total Kin Wai Hung billed 300 services in 9 codes, and Medicare paid $34K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2024-11-26.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99215 Office E&M - Established | Office | 224 | 97 | $117.56 | $26K |
| 99205 Office E&M - New | Office | 16 | 16 | $150.39 | $2,406 |
By year: 2022 $65K for 474 services; 2023 $67K for 535 services; 2024 $34K for 300 services.
Medicare prescription drug claims, 2024
In 2024, the drug Kin Wai Hung prescribed most often to Medicare patients was Tafinlar (Dabrafenib Mesylate), with 35 prescriptions and refills. In total Kin Wai Hung wrote 309 Medicare prescriptions that cost $1.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Tafinlar Dabrafenib Mesylate | 35 | 38 | Under 11 | $450K |
| Levothyroxine Sodium Generic | 33 | 51 | Under 11 | $289 |
| Mekinist Trametinib Dimethyl Sulfoxide | 28 | 31 | Under 11 | $467K |
| Oxycodone Hcl Generic | 20 | 20 | Under 11 | $587 |
| Erivedge Vismodegib | 19 | 19 | Under 11 | $259K |
| Ondansetron Hcl Generic | 18 | 18 | 17 | $147 |
Brand drugs: 98 claims; generic drugs: 211 claims; opioid claims: 34.
Money and other things of value reported by the companies
In 2024, drug and medical device companies paid Kin Wai Hung $7,142 ($7,142 in general payments such as food, travel and fees) from 1 company. The largest payer was Regeneron Pharmaceuticals, Inc. with $7,142.
| Company | Payments | Amount |
|---|---|---|
| Regeneron Pharmaceuticals, Inc. REGN | 4 | $7,142 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.